The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Anthony Letai pledges to ensure stability for extramural and intramural cancer science

Cancer Policy

Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report

Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”

FDA releases draft guidance on reducing testing on non-human primates for monoclonal antibodies

Vaccine skeptic installed as CDC’s new second-in-command

CMS cuts deal on four oncology drugs under Medicare

Medicare Part B premiums expected to rise almost 10% in 2026

Clinical Roundup

ASTRO publishes first guideline focused on radiation therapy for gastric cancer

Montefiore Einstein sees lowest rate of late-stage lung cancer diagnoses in surrounding community

Sylvester researchers lead treatment overhauls for AML

Patients in Nepal experience substantial delays when accessing cancer care, study finds

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

One in 8 adults say they are currently taking a GLP-1 drug for weight loss, diabetes, or another condition, KFF poll finds

In The Clinic
Free

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

Regulatory News
Trials & Tribulations
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account